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D-Glycerate kinase was measured in human livers thanks to a new, sensitive radiochemical ssay. The enzyme was ex- 
tremely unstable inextracts prepared inwater, but was partly stabilized in a homogenization mixture containing inorganic 
phosphate, D-glycerate and EGTA. When extracted in such a stabilizing mixture, glycerate kinase activity amounted 
to 0.86 + 0.21 U/g in control rivers and to 0.03 U/g in the liver of a patient with D-glyceric aciduria. In contrast, D- 
glycerate dehydrogenase (glyoxylate r ductase) and triokinase activities were not deficient in the liver of the same patient. 
It is concluded that D-glycerate kinase deficiency isa cause of D-glyceric aciduria. 
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1. INTRODUCTION 
D-Glycerate,  an intermediate o f  one o f  the 
pathways o f  serine degradat ion and of  a minor  
pathway o f  fructose metabol ism is normal ly  not 
detectable in ur ine [1,2]. It is, however,  excreted in 
large amounts  by a few patients with D-glyceric 
ac idur ia,  a rare inborn error o f  metabol ism 
associated with delayed psychomotor  growth, 
menta l  retardat ion and seizures [1-4].  The en- 
zymatic  defect responsible for this condit ion has 
up to now not  been described, part ly  because of  
the unavai labi l i ty  of  l iver samples f rom patients 
with this disorder,  and part ly  because o f  the lack 
o f  knowledge about  the fate of  D-glycerate in 
humans.  A l though it now seems clear that D- 
glycerate is an intermediate in the degradat ion,  not  
in the synthesis o f  L-serine [5], D-glycerate kinase 
has been reported to be poor ly  active in human 
liver and,  hence, was suspected o f  being devoid o f  
a physiological  role [6]. 
It is shown here that the activity of  D-glycerate 
kinase in normal  human liver has been 
underest imated by previous investigators,  
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presumably  because o f  its great instabi l i ty in ex- 
tracts,  and that this enzyme is pro found ly  deficient 
in the liver of  a new case o f  D-glyceric aciduria.  
2. MATERIALS  AND METHODS 
2.1. Materials 
Coenzymes and auxiliary enzymes were from Boehringer 
(Mannheim, FRG). The hemicalcium salt of D-glycerate, 
lithium hydroxypyruvate, sodium glyoxylate and sodium 
EGTA were from Sigma (St. Louis, MO). Chemicals were from 
Merck (Darmstadt, FRG). Dowex AG 1-X8 was from BioRad 
laboratories (Richmond, CA). 
2.2. Synthesis of D-[l~C]glycerate 
10 ~Ci (40 nmol) of [U-14C]glucose (The Radiochemical Cen- 
tre, Amersham, Bucks) were incubated at 25°C, in a final 
volume of I ml, in the presence of 50 mM Tris, pH 8, 5 mM Mg 
acetate, 200 ~M ATP, 1/~M fructose 2,6-bisphosphate, 50/~M 
AMP, 5 mM sodium arsenate, 1 mM NAD and the following 
mixture of enzymes that had been freed from most of their am- 
monium sulfate by centrifugation a d resuspension i  a 10 mM 
Tris buffer, pH 8, containing 1~M fructose 2,6-bisphosphate, 
10 ~g yeast hexokinase, 10/~g yeast phosphoglucose isomerase, 
50/~g rabbit muscle 6-phosphofructo-l-kinase, 10/~g rabbit 
muscle aldolase, 10/~g rabbit muscle triose-phosphate 
isomerase and 50~g rabbit muscle glyceraldehyde 3-P- 
dehydrogenase. The reaction was followed by measuring ADo 
and was arrested after 90 rain by heating the mixture for 5 rain 
at 80°C. The sample was centrifuged and the resulting superna- 
tant applied on a small (0.5 x 4 cm) AG1-X8 (200-400 mesh, 
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CI form) column. The column was washed successively with 
3 mi water, 3 ml of 0.15 M NaCI and, finally, with 3 x 1 ml of 
0.4 M NaC1 in order to elute glycerate 3-phosphate. The latter 
was converted to D-glycerate by a 60 rain incubation at 30°C in 
the presence of 20 mM Tris, pH 8, 5 mM Mg acetate and 10 #g 
calf intestine alkaline phosphatase in a final volume of 4 ml. 
The reaction was stopped by a 5 rain incubation at 800C. After 
cooling, the mixture was diluted 4-fold with water and applied 
to a 5 cm 3 AG1-X8 column which was washed with 10 ml 
water. D-Glycerate was then ehited with 10 ml of 0.2 M NaCI. 
The overall yield of the conversion of [14C]glucose to D- 
[~4C]giycerate was about 70070. The purity of the final product 
was indicated by the fact that it could be completely 
phosphorylated by a partially (approx. 200-fold) purified 
preparation of rat liver D-glycerate kinase. 
2.3. Human liver specimens 
Two needle biopsies taken from a young female patient with 
D-glyceric aciduria at the age of 9 and 12 months were kindly 
provided by Dr C. Largillibre (Lille). This patient showed 
delayed psychomotor development, axial hypotonia nd spastic 
tetraparesia. The presence of high concentrations (typically 
20-50raM) of D-glyceric acid was disclosed by gas 
chromatography and by enzymatic analysis (Largilli&e, per- 
sonal communication). The full clinical history and the 
biological findings concerning this patient will be reported 
elsewhere (Largilli~re t al., in preparation). The control 
samples used in this study were either biopsy specimens from 
patients suspected of having another metabolic disorder, or 
pieces of donor tissue obtained in the course of liver transplan- 
tations (kindly provided by Professor J.B. Otte, Brussels). The 
liver samples were homogenized in a Kontes glass homogenizer 
with 50 vols of water or of a mixture containing 10 mM Pi, pH 
7.1, 50/zM D-glycerate and 1 mM EGTA. These homogenates 
were used as such for the radiochemical ssay of D-glycerate 
kinase; the supernatant resulting from a 5 rain centrifugation at
10000 × g was used for the other enzymatic assays. 
2.4. Enzyme assays 
In preliminary experiments, D-glycerate kinase was assayed 
by a spectropbotometric procedure [7]. The mixture of this 
assay contained 50 mM Hepes, pH 7.1, 0.15 mM NADH, 
20 mM KCI, 7 mM Mg acetate, 0.1070 Triton X-100, 5 mM 
EGTA, 2.5 mM ATP, 2.5 mM ADP, 1 mM D-glycerate and 
2/~g/ml of rabbit muscle nolase and pyruvate kinase as well as 
10/~g/ml rabbit muscle lactate dehydrogenase. In other ex- 
periments, a radiochemical ssay was used. This assay was in- 
itiated as soon as possible after preparation of the homogenate 
(< 10 min). 50/A homogenate were incubated at 300C in an 
assay mixture containing 50 mM Hepes, pH 7.1, 20 mM KCI, 
7 mM Mg acetate, 0.1070 Triton X-100, 5 mM EGTA, 0.1 mM 
D-[t4C]glycerate (50000 cpm) and 5 mM ATP in a final volume 
of 0.2 ml. EGTA was included in the assay because Ca 2+, which 
is present in the commercial preparation of D-glycerate, was 
found to inhibit glycerate kinase. 50/d portions were removed 
at various times from the reaction mixture and mixed with 
200/zl of 95070 ethanol. These samples were subsequently 
diluted with 1 ml water and applied on small (0.4 × 4 cm) 
Dowex AGI-X8 (el form) columns. The columns were washed 
with 6 ml of 10 mM Tris, pH 8, containing 0.125 mM NaC1 in 
order to elute D-glycerate. Phosphoglycerates were eluted with 
3 ml of 400 mM NaCI in 10 mM Tris, pH 8.2 ml of the latter 
fraction were mixed with 15 ml of Pico Fluor TM 15 (Packard In- 
strument Company) and counted for radioactivity. 
Triokinase was assayed spectrophotometrically at 30°C in an 
assay mixture containing 50 mM Hepes, pH 7.1, 2.5 mM Mg 
acetate and 0.075 mM NADH as well as 2/zg glycerol-3-phos- 
phate dehydrogenase and 0.2/~g triose phosphate isomerase in
a total volume of 1 ml. The assay of D-glycerate dehydrogenase 
(glyoxylate r ductase [8,9]) was performed at 25°C in a mixture 
containing 50 mM Hepes, pH 7.1, 100 mM KCI, 0.125 mM 
NADPH and 200/zM hydroxypyruvate or glyoxylate. Care was 
taken to consider only initial rates, i.e., before 10°70 of the 
substrates had been consumed. Fructose-l,6-bisphosphatase 
was assayed spectrophotometrically at 25 °C in an assay mixture 
(1 ml) containing 50 mM imidazole, pH 8, 50 mM KCI, 20 mM 
Mg acetate, 0.5 mM NADP, 0.2 mM EDTA, 5/~g yeast 
ghicose-6-phosphate dehydrogenase and 50/~g yeast phospho- 
glucose isomerase. One unit of enzyme is the activity cor- 
responding to the formation of 1/zmol of product/min. 
3. RESULTS 
3.1. D-Glycerate kinase assay 
In previous work, D-glycerate kinase was 
measured by a spectrophotometr ic  assay, in which 
the 2-phosphoglycerate formed was converted en- 
zymatical ly to lactate with concomitant  oxidation 
o f  NADH.  In the present work,  it was found that 
the blank, corresponding to the oxidation of  
NADH in the absence o f  D-glycerate, amounted to 
about  1/5th of  the D-glycerate kinase activity pre- 
sent in rat liver ( -3  U /g  fresh wt). It was, 
however,  approximately equal to the D-glycerate 
kinase activity present in human livers (0.13 U /g  
as a mean according to [6]), preventing an accurate 
determinat ion o f  this activity in human biopsy 
specimens. 
It was, therefore, necessary to set up a more sen- 
sitive assay. The method developed in this study is 
based on the ATP-dependent  conversion o f  D- 
[14C]glycerate into [14C]phosphoglycerates, which 
can then be separated by a stepwise salt gradient on 
small AG l -X8 columns. Due to the low Km value 
o f  human liver D-glycerate kinase (approx. 15/~M, 
see below) the activity of  D-glycerate kinase could 
be measured under near Vma~ condit ions with 
100/~M D-glycerate. As i l lustrated in fig. 1, the for- 
14 mat ion of  [ C]phosphoglycerates was readily 
detectable with an amount  of  homogenate cor- 
responding to 0.2 mg liver. This format ion was 
dependent on the presence o f  ATP  and was linear 
with respect o t ime and to the amount  of  extract 
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Fig.l. Time-course of the ATP-dependent conversion of 
[14C]glycerate into phosphoglycerates by a human liver 
homogenate. A sample of human liver homogenate was 
homogenised in 50 vols of 10 mM KPi, pH 7.1, 50/zM D- 
glycerate and 1 mM EGTA. The indicated amounts of resulting 
homogenate were incubated in the D-glycerate kinase assay 
mixture (closed symbols) or in the same mixture except ATP 
was omitted (A). 
Bovine serum albumin at a concentration of 
1 mg/ml, 1 mM phenylmethylsulfonyl fluoride, 
1 mM dithiothreitol, 1 mM EGTA or 10 mM Pi 
did not appreciably stabilize the enzyme (not 
shown). In contrast, the use of a homogenization 
medium containing 10raM KPi, 50/zM D- 
glycerate and 1 mM EGTA not only slowed down 
the loss of D-glycerate kinase activity (fig.2), but 
also resulted in a severalfold higher initial enzymic 
activity (fig.2, table 1). Extraction of the livers 
with water followed immediately by the addition 
of the stabilization mixture was found not to be 
satisfactory, because it yielded an activity amount- 
ing to 30% of the value obtained in homogenates 
prepared irectly in the stabilizing buffer (table 1). 
Table 1 also shows that, whatever the 
homogenization procedure used, the activity of D- 
glycerate kinase was at least 10-fold lower in the 
liver of the patient with D-glyceric aciduria. Mix- 
ing experiments yielded values that were the 
arithmetic means of the activities found in the 
homogenates tested separately, indicating that the 
low activity found in the liver of the patient was 
not due to the presence of an inhibitor (not 
shown). The Km of the patient's enzyme for D- 
added, at least until 25% of the radioactive 
substrate had been consumed. Under the condi- 
tions of the assay, a doubling of the blank value 
(approx. 0.5% of the total radioactivity) in20 min 
corresponded to 5/zU of enzyme, a value which 
was considered to be the detection limit of the 
assay. 
3.2. D-Glycerate kinase assay in human liver 
The activity of D-glycerate kinase present in 
human liver extracts prepared in water (table 1) 
was in close agreement with the mean value of 
0.13 U reported by Heinz et al. [6]. The enzyme 
was, however, quite unstable in such extracts. As 
shown in fig.2, the loss of activity at 0°C was most 
rapid during the first 10 min following 
homogenization and then became progressively 
slower. Because of the rapid initial loss, the activi- 
ty measured as soon as possible (-1 min) after 
homogenization could, nonetheless, be an 
underestimate of the actual value in the liver. It 
was, therefore, of interest to find extraction condi- 
tions that would stabilize the human liver enzyme. 
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Fig.2. Loss of D-glycerate kinase activity in human liver 
homogenates. Samples from a human liver were homogenised 
in 50 vols of water (o) or of a homogenising mixture 
containing 10 mM KPi, 50/~M D-glycerate and 1 mM EGTA 
(o), and the resulting homogenates were maintained at0°C. D- 
Glycerate kinase activity was determined atthe indicated times 
by the radiochemicai ssay. 
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Table 1 
Activity of glycerate kinase and of other enzymes in human liver 
Enzyme Control Range Patient 
Glycerate kinase 
Extraction i  water 0.15 + 0.03 (10) 0.04- 0.32 <0.005 
Pi/D-glyeerate/EGTA 0.86 + 0.21 (5) 0.26- 1.60 0.03 
Water, then supple- 
mented with Pi/D- 
glycerate/EGTA 0.28 + 0.08 (4) 0.12- 0.48 0.03 
Glycerate dehydrogenase 
Substrate: Hydroxypyruvate 19.1 + 1.6 (6) 13.9 -23.1 30.9 
Glyoxylate 11.9 +0.9 (6) 8.8-14.5 14.8 
Triokinase 1.71 _+ 0.31 (8) 0.61- 2.89 1.16 
Fructose-l,6-bisphosphatase 3.7 + 0.6 (6) 2.1-  6.0 5.7 
Enzymatic activities (U/g liver) + SE 
glycerate was not detectably different from the Kra 
of controls (15/~M). In contrast with D-glycerate 
kinase, the activities of fructose-l,6-bisphospha- 
tase and of triokinase were in the normal range. 
The latter enzyme displayed with 200/zM D-gly- 
ceraldehyde about 60o70 of the activity found with 
100/zM dihydroxyacetone both in the patient and 
in controls. It is noticeable that the activity of D- 
glycerate dehydrogenase measured with NADPH 
and either hydroxypyruvate or glyoxylate as 
substrates was slightly above the range of the con- 
trol values. These activities were not attributable to 
lactate dehydrogenase ince the pyruvate depen- 
dent oxidation of NADPH in human liver extracts 
amounted to less than 0.5 U/g. 
4. DISCUSSION 
4.1. D-Glycerate metabolism in the liver 
D-Glycerate arises in higher animals through the 
metabolism of serine and of fructose. Serine can 
indeed be converted by transamination to hydrox- 
ypyruvate, the latter being reduced to D-glycerate 
by D-glycerate dehydrogenase. Although it has 
been believed for some time that these two reac- 
tions might be involved in the biosynthesis of 
serine [10], there is now ample evidence that they 
are part of one of the serine degradation pathways 
[5] and the fact that D-glycerate. dehydrogenase 
deficiency results in the accumulation of L- 
glycerate [11-13], which is produced from hydrox- 
ypyruvate by lactate dehydrogenase [9], is a strong 
argument in support of this thesis. Furthermore, 
liver D-glycerate dehydrogenase displays much 
more affinity for NADPH and NADP (Van Schaf- 
tingen, unpublished) than respectively for NADH 
and NAD, and, since it is located in the cytosol 
[ 14], can presumably only function as a reductase 
in vivo. 
In addition to being converted to hydrox- 
ypyruvate, serine can be deaminated to pyruvate 
by serine deaminase, but the activity of this en- 
zyme has been reported to be negligible in human 
liver [5]. 
D-Glycerate can also be produced by the oxida- 
tion of D-glyceraldehyde, a product of fructose 
metabolism. It appears, however, that, under nor- 
mal circumstances, most of the glyceraldehyde is 
phosphorylated bytriokinase [15], which in human 
liver is fairly active [6]. 
Since, as discussed above, D-glycerate 
dehydrogenase cannot utilise D-glycerate in vivo, 
the only known fate of this compound is to be 
phosphorylated by D-glycerate kinase to 
2-phosphoglycerate. It is shown here that D- 
glycerate kinase activity has been underestimated 
in human liver by previous investigators [6], 
presumably because of its instability. When ex- 
tracts were prepared in the presence of a stabilising 
mixture, a mean value of 0.86 U/g was recorded, 
which may also be an underestimation, since the 
homogenisation medium did not completely 
stabilise the enzyme. 
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4.2. Enzymatic defect in D-glyceric aciduria 
The accumulation of D-glyceric acid in patients 
with D-glyceric aciduria can conceivably result 
either from a decreased utilisation or from an over- 
production of this compound. Since the only fate 
of D-glycerate in the liver appears to be its conver- 
sion to 2-P-glycerate by D-glycerate kinase, it is 
concluded that the marked deficiency of this en- 
zyme found in the liver of the patient studied here 
is responsible for her metabolic disorder. Because 
D-glycerate is an intermediate in serine metabolism 
and that this amino acid is continuously taken up 
by the liver, at least in the rat [16], this interpreta- 
tion accounts for the fact that the excretion of D- 
glycerate was continuous in this patient and that it 
increased following a serine load (Largilli&e, per- 
sonal communication). These two characteristics 
were also found in the patient of Wadman et al. 
[2], who, most likely, suffered from the same en- 
zymatic defect. From the protein intake of this pa- 
tient (2.9 g per day and per kg) and assuming that 
serine represents 5°7o of the protein, it can be 
calculated that the amount of D-glycerate xcreted 
by Wadman's  patient (1.4 mmol /6  h at the age of 
55 days) roughly corresponded to his serine intake. 
Although serine intake is not the only source of 
this amino acid, which indeed is also synthesized 
de novo, this comparison indicates that the 
pathway of serine metabolism via hydrox- 
ypyruvate and D-glycerate is quantitatively impor- 
tant in humans. 
In contrast, D-glycerate overproduction might 
be the cause of the D-glyceric aciduria in the pa- 
tient described by Duran et al. [4]. The excretion of 
D-glyceric acid by this patient was extremely 
dependent on the ingestion of fructose or of 
dihydroxyacetone, and was not influenced by a 
serine load. On this basis, Duran and co-workers 
suggested a triokinase deficiency. It is indeed ex- 
pected that, in the absence of  this enzyme, a major 
part of the glyceraldehyde arising from fructose 
metabolism would be converted to D-glycerate. 
Since the activity of D-glycerate kinase in the liver 
is somewhat lower than the activities of fruc- 
tokinase and of fructose-l-phosphate aldolase 
(respectively 1.23 and 2.08 U/g at 25°C [6]), D- 
glycerate would then escape the liver and be found 
in blood and in urine. This interpretation, 
however, does not account for the fact that the pa- 
tient excreted some D-glycerate on a fructose-free 
regimen. Unfortunately, the possibility that the pa- 
tient had a triokinase deficiency could not be tested 
directly by enzymatic assay. It is noteworthy that 
the triokinase activity was normal in the patieW 
studied here. 
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